Stay updated on BetAvena Study: Beta-Glucan as Add-On to Statin Clinical Trial
Sign up to get notified when there's something new on the BetAvena Study: Beta-Glucan as Add-On to Statin Clinical Trial page.

Latest updates to the BetAvena Study: Beta-Glucan as Add-On to Statin Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.4 (from v3.3.3). No visible changes to page content or study information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedFooter updates: added 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' link (and the previous 'Revision: v3.3.2' reference).SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding operating status notice from the page.SummaryDifference0.4%

- Check72 days agoChange DetectedNo additions or deletions were detected. The page content remains focused on the trial record details, outcomes, and administrative information.SummaryDifference0.1%

- Check101 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference3%

Stay in the know with updates to BetAvena Study: Beta-Glucan as Add-On to Statin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BetAvena Study: Beta-Glucan as Add-On to Statin Clinical Trial page.